永新制药

Jiangsu Yongxin Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates high-standard production facilities that comply with global GMP requirements, focusing on therapeutic areas such as anti-infectives, cardiovascular health, and gastrointestinal treatments. With a strong emphasis on quality control and international export, Yongxin Pharmaceutical serves both domestic and global markets with a diverse portfolio of generic medications. Their business model integrates chemical synthesis with advanced pharmaceutical formulation to provide cost-effective healthcare solutions.